Heart may heal with help from oxygen-sensitive genes, new study suggests

a heart attack," he continued. "But our study is the first to suggest the mechanism behind this differentiation - that a sudden exposure to higher oxygen pressure causes significant changes in the gene expression, looks and function of cardiac fibroblasts."

A heart attack occurs when a clots form, blocking blood flow through a coronary artery. Since a clot develops over time, heart cells slowly adjust to chronic hypoxia a condition of severely reduced oxygen levels. Heart cells have a tremendous ability to survive under low-oxygen conditions, said Sen, adding that sudden re-oxygenation of the tissue at the site of the clot can result in cell injury or death.

"The injured tissue is like a bull's-eye," Sen said. "This area is the most shocked by a rush of oxygen-rich blood.

"Imagine a series of concentric circles surrounding the damage oxygen shock progressively lessens the further you move away from the bull's-eye," he continued. "While the tissue in the bull's-eye is the most shocked and the heart cells here die, the shock at the perimeter of the damage is not lethal.

"This shock at the perimeter serves as a wake-up call to trigger healing. And now you have a healing band of tissue around the injured site."

It's this band of newly formed myofibroblasts that can help the heart replace tissue killed by the heart attack.

"It is important to appreciate that the heart has a built-in, healing component," Sen said. "Focusing on this healing band of tissue at the perimeter of the damaged site is likely to provide effective therapeutic solutions."

He conducted the study with Jay Zweier, Director of the Dorothy M. Davis Heart and Lung Research Institute at Ohio State; Sashwati Roy, Savita Khanna, William Wallace, Jani Lappalainen, Cameron Rink, and Arturo Cardounel, all with the Davis Heart and Lung Research Institute.


Contact: Chandan Sen
Ohio State University

Page: 1 2

Related biology news :

1. Heart gene yields insights into evolution, disease risk
2. Heartless worms hold clues to cardiac arrhythmias, sudden death
3. Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24
4. Heart and lung transplantation clinical trial results to be announced at ISHLT meeting
5. Heart drug might help fight chronic fungal infections
6. Heart disease among some Japanese may be due to sequencing variation inside a gene
7. Heart size and function uncoupled by researchers
8. Heart disease gene linked to prostate cancer
9. Heart-felt stress can be more dangerous to immune system
10. Society for Womens Health Research will be releasing reports related to Heart Month
11. Heart attack in a laboratory dish

Post Your Comments:

(Date:8/9/2019)... ... ... With a demand in healthcare to lower unneeded emergency room visits and ... (UCC) in the coming years, according to a new report on the industry by ... , is a detailed look at the current state of these healthcare outlets, including ...
(Date:8/6/2019)... ... 2019 , ... VetStem Biopharma has long been ... experience. In November it spun out a human regenerative medicine subsidiary, ... of the first cGMP cell manufacturing facilities in California , VetStem signed ...
(Date:8/6/2019)... ... August 05, 2019 , ... ... announce its attendance at the Microscopy & Microanalysis 2019 Meeting ( M&M 2019 ... Oregon Convention Center. , The Microscopy & Microanalysis Meeting, organized by the Microscopy ...
Breaking Biology News(10 mins):
(Date:8/6/2019)... ... 2019 , ... Shoreline Biome, a microbiome research ... has announced partnerships with six international distributors. , The distributors will sell ... Australia, Benelux, Indonesia, Korea, Malaysia, Myanmar, New Zealand, Singapore, the United Kingdom, and ...
(Date:7/26/2019)... ... July 25, 2019 , ... LeadingBiotech , ... dialogue, today announces its Boston BD conference to be held on ... Biotech Week Boston , the event provides an opportunity for attendees to leverage ...
(Date:7/17/2019)... ... July 16, 2019 , ... ... and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for ... will have dedicated manufacturing space at the new, state-of-the-art commercial manufacturing center ...
(Date:7/2/2019)... ... , ... Leading Regenerative Veterinary Medicine company, VetStem Biopharma , was recently ... film focuses on regenerative veterinary medicine as a means of improving the quality of ... in the Brentwood and Pacific Palisades International Film Festival in Los Angeles, California where ...
Breaking Biology Technology:
Cached News: